Effect of high-dose milnacipran in patients with depression

Neuropsychiatric Disease and Treatment

Volumn 3, Issue 5, 2007, Pages 699-702

  Hayashi, Masatoshi ^a   Mimura, Masaru ^a   Otsubo, Tempei ^a   Kamijima, Kunitoshi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dual action antidepressant; High dose; Milnacipran; Paroxetine; Pharmacotherapy

Indexed keywords

MILNACIPRAN; PAROXETINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MAXIMUM PERMISSIBLE DOSE; NAUSEA; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TREMOR;

EID: 36049017053     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Ansseau M, von Frenckell R, Mertens C, et al. 1989. Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients. Psychopharmacology, 98:163-8.
2. Guelfi JD, Ansseau M, Corrubl EJ, et al. 1998. A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients. Int Clin Psychopharmacology, 13:121-8.
3. Kanemoto K, Matsubara M, Yamashita K, et al. 2004. Controlled comparison of two different doses of milnacipran in major depressive outpatients. Int Clin Psychopharmacol, 19:343-6.
4. Morishita S. 2003. A clinical case of relapsed depression improved with high dose of milnacipran. Jpn J Psychiatry, 8:257-60.
5. Puozzo C, Filaquier C, Briley M. 1985. Plasma levels of F 2207, midalcipran, a novel antidepressant, after single oral administration in volunteers. Br J Clin Pharmacol, 20:291.
6. Puozzo C, Leonard BE. 1996. Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psychopharmacol, 11(Suppl 4):15-27.
7. Serre C, Clerc G, Escande M, et al. 1986. An early clinical trial of midalcipran, 1-phenyl-1-diethyl aminocarbonyl 2-aminomethyl cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant. Curr Ther Res Clin Exp, 39:156-64.
8. Suzuki K, Komatsu K, Yamamori S, et al. 2002. Clinical experience of milnacipran hydrochloraide in the stress hospital ward [Japanese]. Jpn J Clin Psychopharmacol, 5:93-9.
9. von Frenckell R, Ansseau M, Serre C, et al. 1990. Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients: A new approach in dose ranging studies. Int Clin Psychopharmacol, 5:49-56.